Our study findings also revealed a noteworthy 2.5-fold upregulation of SLC5A8 and a 2.4-fold upregulation of SLC5A5 in the TERT-negative tumor as compared to the TERT-positive tumor (Fig. 9). The gene discussed is SLC5A5; the disease is neoplasm.